The Immunoregulatory Mechanisms of Human Cytomegalovirus from Primary Infection to Reactivation
Pathogens · 2025
DOI: 10.3390/pathogens14100998 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2025. Verfasst von Xiaodan Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengd…. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections, Virus Activation, Host-Pathogen Interactions. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Human cytomegalovirus (HCMV) establishes lifelong latency following primary infection, residing within myeloid progenitor cells and monocytes. To achieve this, the virus employs multiple immune evasion strategies. It suppresses innate immune signaling by inhibiting Toll-like receptor and cGAS-STING pathways. In addition, the virus suppresses major histocompatibility complex (MHC)-dependent antigen presentation to evade T cell recognition. As the downregulation of MHC molecules may trigger NK cell activation, the virus compensates for this by expressing proteins such as UL40 and IL-10, which engage inhibitory NK cell receptors and block activating signals, thereby suppressing NK cell immune surveillance. Viral proteins like UL36 and UL37 block host cell apoptosis and necroptosis, allowing HCMV to persist undetected and avoid clearance. In settings of profound immunosuppression, such as after allogeneic hematopoietic stem cell transplantation (allo-HSCT) or solid organ transplantation, slow immune reconstitution creates a window for viral reactivation. Likewise, immunosenescence and chronic low-grade inflammation during aging increases the risk of reactivation. Once reactivated, HCMV triggers programmed cell death, releasing viral PAMPs (pathogen-associated molecular patterns) and host-derived DAMPs (damage-associated molecular patterns). This release fuels a potent inflammatory response, promoting further viral reactivation and exacerbating tissue damage, creating a vicious cycle. This cycle of inflammation and reactivation contributes to both transplant-related complications and the decline of antiviral immunity in the elderly. Therefore, understanding the immune regulatory mechanisms that govern the switch from latency to reactivation is critical, especially within the unique immune landscapes of transplantation and aging. Elucidating these pathways is essential for developing strategies to prevent and treat HCMV-related disease in these high-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
- Interventional Diagnosis and Treatment Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.
- Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
- Liver Transplant Center, Transplant Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Room 1121, D5A Building, Chengdu Frontier Medical Science Center, No. 2222 Xinchuan Road, Chengdu 610213, China.
ORCID-Profile: Ting Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Liu, C., & Zhang, T. (2025). The Immunoregulatory Mechanisms of Human Cytomegalovirus from Primary Infection to Reactivation. Pathogens. https://doi.org/10.3390/pathogens14100998
Vancouver
Liu X, Liu C, Zhang T. The Immunoregulatory Mechanisms of Human Cytomegalovirus from Primary Infection to Reactivation. Pathogens. 2025. doi:10.3390/pathogens14100998
BibTeX
@article{Liu2025,
author = {Liu, Xiaodan and Liu, Chang and Zhang, Ting},
title = {The Immunoregulatory Mechanisms of Human Cytomegalovirus from Primary Infection to Reactivation},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14100998}
}
EUVIMED